Sterling Capital Management’s Y-mAbs Therapeutics YMAB Stock Holding History

Sterling Capital Management’s Portfolio YMAB Stock Details YMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-87	Closed	-$392	–	3296
2025 Q2	$392	Buy	87 +49	+129%	+$220	﹤0.01%	3181
2025 Q1	$168	Hold	38	–	–	﹤0.01%	3106
2024 Q4	$298	Hold	38	–	–	﹤0.01%	3082
2024 Q3	$500	Buy	+38	New	+$482	﹤0.01%	2872

Other funds holding YMAB

BIG

Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sterling Capital Management's YMAB Position: Q3 2025 in Review

Sterling Capital Management sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 87 shares — an estimated $392 sold.

Sterling Capital Management first reported a position in YMAB in Q3 2024 and held it in 4 quarters. The position peaked at $500 in Q3 2024. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

Sterling Capital Management reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
Sterling Capital Management sold 87 Y-mAbs Therapeutics shares in Q3 2025, an estimated $392.
Sterling Capital Management first reported a position in Y-mAbs Therapeutics in Q3 2024 and held it in 4 quarters.
Sterling Capital Management's Y-mAbs Therapeutics position peaked at $500 in Q3 2024.
2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on Sterling Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.